HAAG STREIT SURGICAL GMBH & CO KG

Their core work

Haag-Streit Surgical is a German manufacturer of precision ophthalmic surgical instruments and equipment, part of the internationally recognized Haag-Streit Group. Their core business is designing and producing the tools surgeons use to operate on the eye — from surgical microscopes to micro-instrumentation used in procedures like cataract and corneal surgery. In H2020, they participated as an industrial partner bringing real-world clinical device expertise to research consortia working on robotic ophthalmic surgery and corneal regenerative therapies. Their value in collaborative projects lies in translating laboratory research into manufacturable, clinically applicable surgical tools.

What they specialise in

How they've shifted over time

With only two projects launched within a single year of each other (2015 and 2016), a meaningful long-term evolution is difficult to establish from the available data alone. What can be observed is a thematic shift from the engineering side of ophthalmology — robotic micro-surgery systems in EurEyeCase — toward the biomedical and regenerative side with ARREST BLINDNESS, suggesting the company was willing to engage with biological therapy consortia, not only device-focused ones. This breadth hints at a deliberate strategy to stay relevant across the full ophthalmology treatment pathway, from surgical hardware to the science of vision restoration.

Haag-Streit Surgical appears to be broadening from pure instrumentation toward participation in biomedical research consortia addressing the underlying causes of vision loss, which could signal interest in future collaborations combining device manufacturing with cell therapy or tissue engineering.

How they like to work

Haag-Streit Surgical has exclusively participated as a consortium partner, never leading a project — a typical profile for an industrial company that contributes device expertise and clinical context without taking on project management responsibility. Their 22 unique partners across 9 countries over just two projects indicates active engagement in sizeable, multi-stakeholder consortia rather than narrow bilateral arrangements. This pattern suggests they are reliable specialist partners who bring industrial credibility and end-user perspective to academic-led research groups.

The company has built connections with 22 distinct consortium partners across 9 European countries from just two projects — a relatively broad footprint for a limited H2020 participation. Their network spans both ICT and health pillars, reflecting the interdisciplinary nature of modern ophthalmic research.

What sets them apart

Haag-Streit Surgical occupies a rare niche as an established industrial manufacturer of ophthalmic surgical equipment that is also willing to engage directly in EU-funded R&D — a combination that academic consortia find extremely valuable for ensuring research outputs have a realistic path to clinical application. Unlike pure research institutes or generic medical device firms, their specialization is narrow and deep: the surgical eye, at the intersection of precision mechanics, optics, and clinical procedure. For any consortium working on vision surgery, robotic microsystems, or corneal treatment, they offer both a development partner and a potential route to market.

Highlights from their portfolio

• EurEyeCase
  A rare EU-funded project applying robotics specifically to ophthalmologic micro-surgery — an extremely delicate application domain — where Haag-Streit Surgical's precision instrument expertise made them a natural industrial anchor.
• ARREST BLINDNESS
  The larger of their two funded projects (EUR 281,222) and the one with the longest duration (2016–2020), addressing corneal blindness through regenerative therapies — a significant biomedical challenge with high commercial and humanitarian impact.